HTL Biotechnology shines at CPHI Japan 2023
HTL was pleased to share that Antoine Clavier-Choo, HTL head of Asia Pacific, participated in CPHI Japan, one of the largest pharmaceutical events in Asia.
The event was held on April 19-21, 2023, at the Tokyo Big Sight Exhibition Center.
CPHI Japan provided an excellent opportunity for us to network with industry experts, customers, and explore new partnerships and collaborations.
We were excited to learn about the latest trends and innovations in the pharmaceutical industry and share our knowledge and experience with others.
To see our most recent news,
Read more
news from us
-
Articles July 5, 2024
HTL Biotechnology Secures Medical Device Registration in China
Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.
-
Articles June 21, 2024
HTL Biotechnology at CPHI China 2024
CPHI China is one of Asia’s leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,
-
Articles June 13, 2024
Discover our Quality Policy
At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.